Body Fluid Analysis Market worth $3.65 billion by 2031
The report "Body Fluid Analysis Market by Product (Consumables, Instruments), Technology (Immunoassay, PCR, Flow Cytometry), Fluid Type (CSF, Pleural, Synovial, Peritoneal, Semen), Application (Clinical Diagnostics, Forensic, Research) - Global Forecast to 2031" is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031, at a CAGR of 6.9%.
Browse 300 market data Tables and 51 Figures spread through 350 Pages and in-depth TOC on "Body Fluid Analysis Market, by Product (Consumables, Instruments), Technology (Immunoassay, PCR, Flow Cytometry), Fluid Type (CSF, Pleural, Synovial, Peritoneal, Semen), Application (Clinical Diagnostics, Forensic, Research) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/body-fluid-analysis-market-51260937.html
The body fluid analysis market is experiencing significant growth, largely fueled by the escalating global incidence of various diseases, which creates a continuous demand for advanced body fluid diagnostics. Additionally, the increasing requirements for forensic testing and heightened research activities are further propelling market expansion. Expanding access to specialist diagnostic infrastructure across emerging economies and the broadening pipeline of approved therapeutics for neurodegenerative and oncological conditions are further accelerating adoption of automated, high-throughput body fluid analysis platforms across end users.
The consumables segment accounted for the largest share of the body fluid analysis market in 2025.
Based on products, the body fluid analysis market is divided into consumables and instruments. The consumables segment accounted for the largest share of the body fluid analysis market in 2025. Consumables in this market include reagent kits, assay panels, stains, and others used across cerebrospinal, serous, synovial, and reproductive fluid testing workflows. Their dominant share reflects the high-frequency, recurring nature of fluid analysis; each patient specimen requires a fresh set of reagents, and growing test volumes driven by disease diagnosis workups translate directly into sustained reagent demand. The shift from single-analyte manual methods toward multi-parameter immunoassay and flow cytometry panels further increases per-test consumable consumption, a trend that will sustain this segment's leading position through the forecast period.
The immunoassay segment is projected to register the highest CAGR in the body fluid analysis market during the forecast period.
The body fluid analysis market, by technology, is divided into microscopic examination, clinical chemistry, flow cytometry, immunoassay, polymerase chain reaction, and other technologies. The immunoassay segment is expected to witness the highest growth during the forecast period, driven by the increasing adoption of biomarker-based testing for neurological disorders, infectious diseases, and inflammatory conditions. The growing use of automated immunoassay platforms for cerebrospinal fluid (CSF) biomarker analysis. Furthermore, rising regulatory approvals, increasing demand for standardized and high-throughput testing, and the shift toward precision diagnostics are accelerating the adoption of immunoassay technologies across end users.
Asia Pacific is expected to register the highest growth rate in the body fluid analysis market during the forecast period.
Market segmentation has been done by dividing the body fluid analysis market into five important regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to grow at the highest CAGR from 2026 to 2031. China, Japan, and India are the primary growth markets within the region. Japan has a well-established diagnostics infrastructure, with an aging population driving demand for testing for disease. China’s national health modernization programs are expanding hospital laboratory capacity and increasing access to specialist IVD platforms. India’s rapidly growing network of tertiary-care hospitals and diagnostic laboratory chains is adopting automated body fluid analysis systems to support growing clinical caseloads in infectious disease and oncology. North America held the largest regional share in 2025, supported by a mature clinical laboratory infrastructure, established reimbursement pathways for CSF biomarker assays, and a high concentration of diagnostic technology manufacturers.
The major market players covered in the report include Sysmex Corporation (Japan); F. Hoffmann-La Roche Ltd. (Switzerland); Danaher Corporation (US), bioMerieux SA (France); Abbott Laboratories (US); Thermo Fisher Scientific (US); QIAGEN N.V. (Netherlands); Revvity (US); Siemens Healthineers AG (Germany); and Becton, Dickinson and Company (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Body Fluid Analysis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
